AV, Y., B, S., K, K., U, K., A, E., A, R., . . . I, A. (2026). Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04334-4
Chicago Style (17th ed.) CitationAV, Yumashev, Shuxrat B, Khayotbek K, Kodirov U, Elmurodova A, Rufat A, Urinova N, and Abduraxmonova I. "Circulating Tumor DNA-based Detection of Molecular Residual Disease in Isocitrate Dehydrogenase-mutant Cholangiocarcinoma for Biomarker-guided Therapy." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04334-4.
MLA (9th ed.) CitationAV, Yumashev, et al. "Circulating Tumor DNA-based Detection of Molecular Residual Disease in Isocitrate Dehydrogenase-mutant Cholangiocarcinoma for Biomarker-guided Therapy." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04334-4.
